TickerFactsScreenerDevelopers

NovoCure Ltd (NVCR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $34.89M2013: $175.89M2014: $57.61M2015: $119.42M2016: $99.78M2017: $78.59M2018: $140.62M2019: $177.32M2020: $234.67M2021: $208.80M2022: $115.33M2023: $240.82M2024: $163.77M2025: $93.55M$93.55M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$93.55M-42.9%
2024$163.77M-32.0%
2023$240.82M+108.8%
2022$115.33M-44.8%
2021$208.80M-11.0%
2020$234.67M+32.3%
2019$177.32M+26.1%
2018$140.62M+78.9%
2017$78.59M-21.2%
2016$99.78M-16.4%
2015$119.42M+107.3%
2014$57.61M-67.2%
2013$175.89M+404.1%
2012$34.89M—